CGTBiologicstaleNational Cancer Institute (NCI)Phase 2
anti-gp100:154-162 Tcell receptor (TCR, anti-gp100:154-162 Tcell receptor, anti-gp100:154-162 Tcell receptor (TCR) peripheral blood lymphocyte (PBL))
Metastatic Melanoma; Skin Cancer · Metastatic Melanoma
#MetastaticMelanoma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 DISCONTINUED